Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak
Anucha
A
Mundy
Linda M
LM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002438:Cefoperazone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005578:Fosfomycin / Q000627:therapeutic use; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*; D013407:Sulbactam / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D005672:Fusidic Acid; D002438:Cefoperazone; D013407:Sulbactam; D012293:Rifampin